# PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows

> **NCT07387510** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Haitao Niu, MD** · enrollment: 27 (estimated)

## Conditions studied

- Prostate Cancer Patients Undergoing Radical Prostatectomy

## Interventions

- **DRUG:** 12 h before RP
- **DRUG:** 24 h before RP
- **DRUG:** 36 h before RP

## Key facts

- **NCT ID:** NCT07387510
- **Lead sponsor:** Haitao Niu, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2026-07-27
- **Final completion:** 2026-09-27
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07387510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07387510, "PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07387510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*